Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Suzhou Zelgen Biopharmaceuticals Co.,Ltd"
Count: 64
Selected: 0
NCT IDTitle
NCT04612712A Phase 1/2 Study of Donafenib in Combination With KN046 in Advanced Gastrointestinal Tumors
NCT02645981Efficacy and Safety of Donafenib in Patients With Advanced Hepatocellular Carcinoma
NCT02229071Safety and Efficacy of Donafenib in Patients With Advanced Hepatocellular Carcinoma
NCT06246695A Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics of Jaktinib in Healthy Volunteers
NCT06241235Study of ZG005 in Combination With Paclitaxel+Platinum-based ± Bevacizumab in Patients With Advanced Cervical Carcinoma
NCT06239298A Study of ZG005 Combined With Donafenib in Patients With Advanced Solid Tumor
NCT06237413A Study of ZG2001 in Participants With KRAS Mutated Advanced Solid Tumours
NCT06237400A Study of ZG19018 in Patients With KRAS G12C Mutant Advanced Solid Tumors.
NCT06233292A Study of ZG005 in Patients With Advanced Solid Tumors
NCT04312594Study of Jaktinib Hydrochloride Tablets in Participants With Idiopathic Pulmonary Fibrosis
NCT06132243Comparative Study on Pharmacokinetics of Two Formulations of Jaktinib in Healthy Adults Under Fasting Conditions
NCT05861128Extension Study to Evaluate Safety and Efficacy of Jaktinib in Patients With Active Ankylosing Spondylitis(AS)
NCT05150717ADME Study of [14C]-Jaktinib in Healthy Male Subjects
NCT04993404Pharmacokinetics Of Jaktinib In Subjects With Hepatic Impairment And Normal Hepatic Function
NCT06193148A Study to Evaluate the Effect of Jaktinib on QT/QTc Interval in Healthy Participants
NCT04617028Jaktinib Versus Hydroxycarbamide in Subjects With Intermediate-2 or High-risk Myelofibrosis
NCT05978284Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
NCT04851535Study of Jaktinib In Patients With Myelofibrosis Who Were Relapsed or Refractory of Ruxolitinib Treatment.
NCT05688839A Study of Jaktinib Hydrochloride Tablets in the Treatment of Severe Novel Coronavirus Pneumonia
NCT05686629An Efficacy and Safety Study of Jaktinib Hydrochloride Tablets in the Treatment of Severe Novel Coronavirus Pneumonia
NCT04211922Alkotinib Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib
NCT05877664Study of ZG0895.HCl in Patients With Advanced Solid Tumors
NCT05702788Efficacy and Safety of Jaktinib in Participants With Severe Novel Coronavirus Pneumonia(COVID-19)
NCT05255237Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata
NCT04964284Efficacy and Safety Study of rhTSH for Adjuvant Radioiodine Ablation Therapy in Patients With Differentiated Thyroid Cancer
NCT04447183The Safety and Effectiveness of rhTSH in Radioiodine Treatment for Patients With Differentiated Thyroid Cancer.
NCT05676242A Phase III Extended Clinical Trial of Jaktinib Hydrochloride Tablets in the Treatment of Moderate and Severe Atopic Dermatitis
NCT05526222A Phase III Study of Jaktinib in Adults With Moderate and Severe Atopic Dermatitis
NCT05584800Study of ZGGS18 in Patients With Advanced Solid Tumors
NCT05864573Study of ZGGS15 in Patients With Advanced Solid Tumors
NCT05051761Study to Evaluate the Safety and Efficacy of Jaktinib in Adults With Alopecia Areata
NCT04445363A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata
NCT05861102Efficacy and Safety Study of Jaktinib in Subjects With Active Ankylosing Spondylitis(AS)
NCT02489201A Study of Donafenib Monotherapy in Advanced Oesophageal Cancer
NCT02698111Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma
NCT02489214Donafenib Monotherapy for Previously Treated Metastatic Gastric Cancer
NCT04217993Jaktinib for the Treatment of Ruxolitinib Intolerance of Myelofibrosis
NCT03607188Study of Alkotinib in Patients With Advanced Non Small Cell Lung Cancer
NCT04507659Jaktinib Hydrochloride Tablets In The Treatment of Active Ankylosing Spondylitis
NCT04539639Clinical Study of Jaktinib in the Treatment of Patients With Moderate and Severe Atopic Dermatitis
NCT04435392Jaktinib Hydrochloride Cream For Atopic Dermatitis
NCT04971473Comparison of the Efficacy and Safety of rhTSH as An Adjunctive Diagnostic Tool in Differentiated Thyroid Cancer Patients Who Had Been Thyroidectomized Vs. Patients Who After Thyroid Hormone Withdrawal
NCT04866056Jaktinib and Azacitidine In Treating Patients With MDS With MF or MDS/MPN With MF.
NCT04402723Combination of Donafenib and Cytarabine/Daunorubicin in Relapsed AML
NCT04971551A Study of Jaktinib for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease.
NCT04612699A Phase 2 Study of Jaktinib in Participants With Moderate to Severe Psoriasis
NCT04605185Donafenib and Toripalimab Combined With TACE in Patients With Unresectable Hepatocellular Carcinoma
NCT04503902Toripalimab Combined With Donafenib in the Treatment of Advanced Hepatocellular Carcinoma
NCT04472858A Study of CS1001 in Combination With Donafenib in Subjects With Advanced Solid Tumors
NCT04459871Safety and Efficacy of Topical Recombinant Human Thrombin(rhThrombin) for Surgical Hemostasis